5, Supplementary Movies 13)
His research interests include understanding the cellul
This compound may be useful in treating conditions like diabetes, polycystic ovary syndrome (PCOS), and non-alcoholic fatty liver disease (NAFLD)
Asia-Pacific GLP-1 Receptor Agonists Obesity Drugs Market Insight The Asia-Pacific GLP-1 receptor agonists obesity drugs market is projected to grow at the fastest CAGR from 2025 to 2032, driven by rising obesity rates, growing middle-class populations, and increasing healthcare investments across countries such as China, Japan, and India
(, ),
This segment benefits from established retail channels, including health food stores, online platforms, and pharmacies, which facilitate broad accessibility